95 studies found for:    Open Studies | "Bile Duct Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
Condition: Primary Biliary Cirrhosis
Intervention: Drug: LUM001
22 Recruiting Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing Cholangitis
Intervention: Drug: Interleukin 2
23 Unknown  Ursodeoxycholic Acid And Cholestasis Of Pregnancy
Condition: Intrahepatic Cholestasis of Pregnancy
Interventions: Drug: Ursodeoxycholic Acid;   Drug: Placebo
24 Recruiting Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
Condition: Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention: Drug: LUM001
25 Recruiting Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review
Condition: Alagille Syndrome
Intervention:
26 Recruiting Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
Conditions: Primary Sclerosing Cholangitis;   Biliary Atresia
Intervention: Drug: Oral Vancomycin
27 Recruiting Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis
Conditions: Hepatitis B;   Cholestasis
Interventions: Drug: Ademetionine   2;   Drug: Ademetionine 1;   Drug: Ademetionine 3
28 Recruiting Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
Condition: Parenteral Nutrition Associated Cholestasis
Intervention: Drug: intravenous lipid
29 Recruiting IBAT Inhibitor A4250 for Cholestatic Pruritus
Condition: Biliary Cirrhosis, Primary
Intervention: Drug: A4250
30 Recruiting in Vivo TICE (TransIntestinal Cholesterol Excretion)
Condition: Occlusion of Bile Duct With an External Bile Diversion.
Intervention: Other: Intravenous injection of deuterated cholesterol diluted in intralipid 20%
31 Recruiting Biliary Atresia Research Consortium
Conditions: Biliary Atresia;   Cholestasis
Intervention:
32 Recruiting Preventing Cholestasis Using SMOFLipid®
Conditions: Cholestasis;   Psychomotor Disorders, Developmental
Interventions: Drug: SMOFLIPID;   Drug: INTRALIPID
33 Recruiting B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
Conditions: Fatigue;   Primary Biliary Cirrhosis
Interventions: Biological: Rituximab;   Other: Placebo
34 Recruiting Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
Condition: Primary Sclerosing Cholangitis
Intervention:
35 Not yet recruiting Fish Oil Lipid Emulsion for the Prevention and Treatment of Parenteral-Nutrition-Associated Liver Disease in Infants
Conditions: Total Parenteral Nutrition-induced Cholestasis;   Cholestasis;   Short Bowel Syndrome;   Gastroschisis;   Intestinal Atresia;   Infant, Premature, Diseases;   Cholestasis of Parenteral Nutrition
Interventions: Drug: Fish oil-based lipid;   Drug: Soybean-based lipid
36 Recruiting Pentoxifylline Therapy in Biliary Atresia
Condition: Biliary Atresia
Intervention: Drug: Pentoxifylline
37 Recruiting Winged Perimeter Versus Traditional Plastic Biliary Stent for Malignant Bile Duct Obstruction
Condition: Malignant Tumor of Extrahepatic Bile Duct
Interventions: Device: WInged perimeter biliary stent insertion (Viaduct);   Device: traditional polyethylene stent insertion (Cotton Huibregtse)
38 Unknown  NPD Measurements in PSC Patients
Condition: Primary Sclerosing Cholangitis
Intervention:
39 Recruiting Phase 3 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cirrhosis
Condition: Liver Cirrhosis, Biliary
Interventions: Drug: Obeticholic Acid (OCA);   Drug: Placebo
40 Not yet recruiting A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
Condition: Primary Sclerosing Cholangitis
Intervention: Drug: BTT1023

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years